Charlotte Ersboll

Senior Adviser, Safe Birth Advocacy and Partnership, Ferring Pharmaceuticals A/S

Former senior executive in leading global PR and public affairs consultancies, advising global healthcare industry and NGOs on communications, reputation and brand positioning strategies as well as public health campaigns, health advocacy and policy development issues. Jan. 2005, joined Novo Nordisk. Currently, Corporate Vice-President, Corporate Stakeholder Engagement,. Responsible for corporate sustainability, corporate public affairs, government affairs and trade policy. Directs the company's global access to diabetes care strategy. Responsible for the development and implementation of global Changing Diabetes® and Changing Possibilities in Haemophilia® leadership initiatives. Involved in initiatives promoting social change, particularly in the field of health and development. Council Member, Novo Nordisk Haemophilia Foundation. Member of Global Support Group, International Committee of the Red Cross.

关于我们

加入我们

  • 登录
  • 成为我们的合作伙伴
  • 成为我们的会员
  • 订阅我们的新闻稿
  • 联系我们

快捷链接

语言版本

隐私政策和服务条款

站点地图

© 2025 世界经济论坛